CRLBF logo
Cresco Labs Inc.(CRLBF)
Closing price · checked 9:30 AM ESTAbout this dataData status
$0.59▼-0.03 (-5.17%)Earnings tomorrow
After Hours:$0.59+0.00 (+0.07%)

Cresco Labs Inc. is a vertically integrated cannabis company based in Illinois, operating in multiple states including Pennsylvania and California. The company focuses on cultivating, manufacturing, and distributing cannabis products, leveraging its extensive dispensary network to capture market share in the growing legal cannabis sector.

HealthcareDrug Manufacturers - Specialty & Genericmoderate - The company has a mix of fixed and variable costs, with significant investments in cultivation facilities and retail locations, but also benefits from scalable production capabilities.

Business Overview

01Retail sales from dispensaries - 65%
02Wholesale distribution to other dispensaries - 25%
03Product manufacturing - 10%

Cresco Labs generates revenue primarily through retail sales in its dispensaries, which are strategically located in high-demand markets. The company benefits from economies of scale in cultivation and manufacturing, enabling it to maintain competitive pricing and product quality. Its extensive product range, including flower, edibles, and concentrates, enhances customer loyalty and market penetration.

What Moves the Stock

Changes in state-level cannabis regulations affecting market access

Consumer demand trends for cannabis products, particularly in key states like Illinois and California

Market share shifts due to competitive actions from other cannabis producers

Financial performance metrics such as gross margin and operating cash flow

Watch on Earnings
Gross margin percentageRetail sales growth rateOperating cash flow figures

Risk Factors

Regulatory changes that could restrict market access or increase compliance costs

Potential federal legalization of cannabis, which could alter competitive dynamics

Increased competition from both established players and new entrants in the cannabis market

Price wars that could erode margins

High debt levels could strain liquidity, especially if revenue continues to decline

Negative net income indicating potential cash flow issues

StructuralCompetitiveBalance Sheet

Macro Sensitivity

Economic Cycle

moderate - The cannabis industry is somewhat insulated from economic downturns, but consumer spending patterns can still impact sales.

Interest Rates

Higher interest rates could increase financing costs for Cresco Labs, impacting expansion plans and operational cash flow. Additionally, higher rates may dampen consumer spending on discretionary items, including cannabis.

Credit

moderate - The company's debt-to-equity ratio of 1.75 indicates a reliance on debt financing, which could be impacted by credit market conditions.

Live Conditions
Russell 2000 FuturesS&P 500 FuturesDow Jones Futures

Profile

growth - Investors seeking exposure to the expanding cannabis market and potential for high returns.

high - The stock has exhibited significant price fluctuations, as evidenced by a 42.4% decline over the past six months.

Key Metrics to Watch
Retail sales growth rate in key states
Gross margin percentage
Operating cash flow
Debt-to-equity ratio
Market share in the cannabis sector
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.